Atara Biotherapeutics, Inc.Atara Biotherapeutics, Inc.Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.32 USD per share, beating the −0.32 USD estimate by −1.59%. Revenue for the same period reached ‪630.00 K‬ USD, despite the estimate of ‪550.00 K‬ USD. For the next quarter, analysts expect −0.13 USD in earnings per share and ‪800.00 K‬ USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise